2011
DOI: 10.1210/jc.2010-2563
|View full text |Cite
|
Sign up to set email alerts
|

Insufficient Activation of Autophagy Allows Cellular Damage to Accumulate in Critically Ill Patients

Abstract: Insufficient autophagy in prolonged critical illness may cause inadequate removal of damaged proteins and mitochondria. Such incomplete clearance of cellular damage, inflicted by illness and aggravated by hyperglycemia, could explain lack of recovery from organ failure in prolonged critically ill patients. These data open perspectives for therapies that activate autophagy during critical illness.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
115
0
3

Year Published

2012
2012
2024
2024

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 188 publications
(123 citation statements)
references
References 47 publications
5
115
0
3
Order By: Relevance
“…Autophagy signaling is not normal in critically ill patients (28), therefore regulation is a potential therapeutic target to improve for disease treatment. The synthesized peptide Tatbeclin-1 induces the autophagy process; mice treated with Tat-beclin-1 were resistant to several infectious diseases (29).…”
Section: Discussionmentioning
confidence: 99%
“…Autophagy signaling is not normal in critically ill patients (28), therefore regulation is a potential therapeutic target to improve for disease treatment. The synthesized peptide Tatbeclin-1 induces the autophagy process; mice treated with Tat-beclin-1 were resistant to several infectious diseases (29).…”
Section: Discussionmentioning
confidence: 99%
“…An analysis that examined liver and skeletal muscle from critically ill patients utilized tissue biopsies that were taken within 30 ± 20 min after death and were flash-frozen in liquid nitrogen followed by storage at -80°C. 815 Samples could subsequently be used for EM and western blot analysis.…”
Section: 792mentioning
confidence: 99%
“…Indeed, we demonstrated a reduction of triglyceride content in non-adipose tissues, such as liver and skeletal muscle, a reduction which was even more pronounced with nutrient restriction. Our observation of triglyceride reduction in liver does not contradict the known occurrence of fatty liver in critically ill patients, because our mouse model was well controlled for hyperglycemia, which is a major trigger for hepatic steatosis during critical illness [29,30]. …”
Section: Discussionmentioning
confidence: 81%